CIK 0001689548 · Large accelerated filer
Praxis Precision Medicines, Inc.
Sign in to watch- Ticker
- PRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-300-8460
- Business address
- 99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-11 | BSOF Parallel Master Fund L.P. 10% owner | Sale | −17,222 | $15.03 | $259K | 812,002 |
| 2021-08-03 | BSOF Parallel Master Fund L.P. 10% owner | Sale | −22,300 | $14.99 | $334K | 829,224 |
| 2021-08-02 | BSOF Parallel Master Fund L.P. 10% owner | Sale | −40,000 | $15.78 | $631K | 851,524 |
| 2021-07-30 | BSOF Parallel Master Fund L.P. 10% owner | Sale | −15,854 | $15.68 | $249K | 891,524 |
| 2021-06-08 | MITCHELL DEAN J Director | Grant or award · Stock Option (Right to Buy) | +22,343 | 22,343 | ||
| 2021-06-08 | Vitorovic Stefan Director | Grant or award · Stock Option (Right to Buy) | +22,343 | 22,343 | ||
| 2021-06-08 | YOUNG WILLIAM D Director | Grant or award · Stock Option (Right to Buy) | +22,343 | 22,343 | ||
| 2021-06-08 | Norden Gregory Director | Grant or award · Stock Option (Right to Buy) | +22,343 | 22,343 | ||
| 2021-05-25 | Kelly Timothy Edwin Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-05-13 | YOUNG WILLIAM D Director | Other acquisition | +28,473 | 28,473 | ||
| 2021-05-12 | Norden Gregory Director | Other acquisition | +2,826 | 2,826 | ||
| 2021-05-12 | Clarus Lifesciences III, L.P. 10% owner | Other disposition | −2,700,000 | 4,894,109 | ||
| 2021-04-28 | Cudkowicz Merit Ester Director | Grant or award · Stock Option (Right to Buy) | +38,579 | 38,579 | ||
| 2021-04-13 | Chodakewitz Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +38,579 | 38,579 | ||
| 2021-02-12 | Sweeny Nicole Chief Commercial Officer | Grant or award | +16,800 | 16,800 | ||
| 2021-02-12 | Sweeny Nicole Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +58,880 | 58,880 | ||
| 2021-02-12 | Nemiroff Alex General Counsel and Secretary | Grant or award | +12,400 | 12,400 | ||
| 2021-02-12 | Nemiroff Alex General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +43,400 | 43,400 | ||
| 2021-02-12 | Mastrocola Lauren Principal Accounting Officer | Grant or award | +8,200 | 20,418 | ||
| 2021-02-12 | Mastrocola Lauren Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +48,700 | 48,700 |
Page 14 of 17 · 331 trades